Haiwei Mou

The Wistar Institute — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

24h-index3.8kcitations58works1.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

CRISPR and Genetic Engineering(20), RNA Interference and Gene Delivery(6), RNA and protein synthesis mechanisms(5), RNA Research and Splicing(5), Cancer Immunotherapy and Biomarkers(4)

Publications57 total

DR5 CAR-T cells target melanoma and suppress MDSCs with minimal toxicity
Molecular Therapy·2025Open Access
Editorial: Insights in genome editing in human health and disease 2023/2024
Frontiers in Genome Editing·2025Open Access
Clonal dynamics shaped by diverse drug-tolerant persister states in melanoma resistance
2025Open Access
DR5 CAR-T cells target solid tumors and suppress MDSCs with minimal toxicity
2025Open Access
Engineered extracellular vesicles with DR5 agonistic scFvs simultaneously target tumor and immunosuppressive stromal cells
Science Advances·2025· 15 citedOpen Access
The Landscape of Gain and Loss of Function Mutations in Melanoma
SSRN Electronic Journal·2025Open Access
The landscape of gain and loss of function mutations in melanoma
2024Open Access
Abstract 4399: HMGA1 is an epigenetic regulator and plays a critical role in melanoma recurrence
Cancer Research·2024
Patient-derived melanoma organoid models facilitate the assessment of immunotherapies
EBioMedicine·2023· 70 citedOpen Access
<scp>CRISPR</scp> ‐induced exon skipping of β‐catenin reveals tumorigenic mutants driving distinct subtypes of liver cancer
The Journal of Pathology·2023· 4 citedOpen Access
The transcription factor TCFL5 responds to A-MYB to elaborate the male meiotic program in mice
Reproduction·2022· 23 citedOpen Access
A path to translation: How 3D patient tumor avatars enable next generation precision oncology
Cancer Cell·2022· 59 citedOpen Access
A-MYB/TCFL5 regulatory architecture ensures the production of pachytene piRNAs in placental mammals
RNA·2022· 25 citedOpen Access
CRISPR-induced exon skipping of β-catenin reveals tumorigenic mutants driving distinct subtypes of liver cancer
2022· 2 citedOpen Access
Dietary suppression of MHC class II expression in intestinal epithelial cells enhances intestinal tumorigenesis
Cell stem cell·2021· 129 citedOpen Access
The testis-specific transcription factor TCFL5 responds to A-MYB to elaborate the male meiotic program in placental mammals
2021· 1 citedOpen Access
Dietary suppression of MHC-II expression in intestinal stem cells enhances intestinal tumorigenesis
2020Open Access
YAP1 Withdrawal in Hepatoblastoma Drives Therapeutic Differentiation of Tumor Cells to Functional Hepatocyte‐Like Cells
Hepatology·2020· 21 citedOpen Access
Evolutionarily conserved pachytene piRNA loci are highly divergent among modern humans
Nature Ecology & Evolution·2019· 115 citedOpen Access
Tissue-restricted genome editing in vivo specified by microRNA-repressible anti-CRISPR proteins
RNA·2019· 97 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Wen Xue(21), Zhiping Weng(16), Deniz M. Özata(15), Hao Yin(11), Chun‐Qing Song(10), Yingxiang Li(10), Daniel G. Anderson(8), Jordan L. Smith(8), Soren Hough(7), Erik J. Sontheimer(7), Yingying Le(7), Jill E. Moore(6), Xiao‐Ou Zhang(6), Tianxiong Yu(6), Ankur Sheel(5), Alper Küçükural(5), Phillip D. Zamore(5), Meenhard Herlyn(5), Qiongqiong Wu(4), Suet‐Yan Kwan(4)